Archives for September 7, 2005

← 2005

New approach in TB treatment

By  Wai Lang Chu

A new immunotherapeutic approach for the treatment of tuberculosis (TB) is set to open up new avenues of laboratory research that sidesteps the associated side effects of current conventional treatments and provides a solution to the threat of...

Lab ventilation systems enter the 21st century

By  Wai Lang Chu

Fundamental changes are occurring in not only the way scientific research is conducted but also innovations that will drive a very different approach to laboratory design in the new millennium.

GSK continues apace with flu vaccine empire building

By Phil Taylor

If there was any doubt that GlaxoSmithKline aims to become the premier world supplier of influenza vaccine, it should be laid to rest by yesterday's news that the number two drugmaker is buying Canadian company ID Biomedical.

Wyeth opens $2bn biomanufacturing plant

Wyeth yesterday formally opened its Grange Castle biotech production facility in South County Dublin, Ireland, one of the largest integrated biotech manufacturing facilities in the world.

Nasal Alzheimer's drug to enter trials

A clinical trial will shortly get underway to see if insulin, delivered intranasally using an atomiser developed by Kurve Technology, can improve short-term memory in Alzheimer's disease patients.

Crucell and Aeras announces unique TB vaccine trials

By  Wai Lang Chu

Dutch biotechnology company Crucell and the Aeras Global TB Vaccine Foundation has announced the initiation of a series of clinical studies for a unique TB vaccine, which allows millions of doses to be manufactured simultaneously while keeping...

Evotec reorganises development services business

By Phil Taylor

Anglo-German company Evotec has reorganised its pharmaceutical development services business by integrating its ProPharma subsidiary, based in Scotland, into a new structure alongside its in-house activities.

Organisations address laboratory research safeguards

By  Wai Lang Chu

Medical research bodies have joined together in a defiant effort to combat terrorism by issuing a statement that aims to reduce the risk of sensitive laboratory research being used in bioterrorism.